Search

everythinglearnresearchcommunity

for

Search:↓

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Mutants of CYP154C2 enzyme significantly improved steroid conversion efficiency.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

The S9 fraction with GC-IDMS is effective for measuring 5α-reductase activity.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Men with male pattern baldness have lower levels of the antioxidant PON1.

Reconstructed skin models are useful for studying how skin processes certain chemicals.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Eclipta alba extract could be a promising natural treatment for hair loss.

Scale created to measure hair loss in men and women; MK-386 reduces acne; Niaspan treats dyslipidemia; minoxidil increases heart rate.

Women also use 5α-reductase inhibitors, and their effects differ from men.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

Suppressing ODC activity reduces tumor growth in hair follicles.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

SCD1 is crucial for skin health and overall energy balance.